The incidence and prevalence of HIV infection among childbearing women living in Edinburgh city, 1982-1995

AIDS

Volumn 12, Issue 8, 1998, Pages 911-918

  Johnstone, Frank ^a   Goldberg, David ^b   Tappin, David ^c   Mathie, Lindsay ^c   Cameron, Sheila ^d   Brown, Ariene ^c   Burns, Sheila ^e   Hamilton, Barbara ^a   Codere, Glen ^b   Anthony Girdwood, R W ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Scottish Centre for Infection and Environmental Health   (United Kingdom)

^c NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^d Regional Virus Laboratory   (United Kingdom)

^e CITY HOSPITAL   (United Kingdom)

Author keywords

Childbearing women; Edinburgh; HIV incidence; HIV prevalence; Pregnant

Indexed keywords

ARTICLE; CITY; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MOTHER; NEWBORN; PREGNANCY; PRIORITY JOURNAL; UNITED KINGDOM;

COHORT STUDIES; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INCIDENCE; INFANT, NEWBORN; NEONATAL SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SCOTLAND; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 7144264413     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199808000-00014     Document Type: Article

References (25)

1. Peutherer JF, Edmond E, Simmonds P, Dickson JD, Bath GE: HTLV-III antibody in Edinburgh drug addicts [letter]. Lancet 1985, ii:1129-1130.
2. Robertson JR, Bucknall ABV, Welsby PD, et al.: Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug users. BMJ 1986, 292:527-529.
3. Tappin DM, Cirdwood RWA, Follett EAC, Kennedy R, Brown AJ, Cockburn F: Prevalence of maternal HIV infection in Scotland, based on unlinked anonymous testing of newborn babies. Lancet 1991, 337:1565-1567.
4. Tappin DM, Cirdwood RWA, Follett EAC, Kennedy R, Brown AJ, Cockburn F: Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Update. Scot Med J 1993, 38:16-17.
5. Goldberg D, Davis B, Allardice G, McMenamin J, Codere G: Monitoring the spread of HIV and AIDS in Scotland 1983-1994. Scot Med J 1996, 41:131-138.
6. Tappin DM, Cirdwood RWA, Kennedy R, et al.: An audit of infants 'unscreened' by the neonatal screening system in Scotland during 1991. Screening 1995, 3:201-207.
7. Peckham CS, Tedder RS, Briggs M, et al.: Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet 1990, 335:516-519.
8. Johnstone FD, Raab GM, Hamilton BA: The effect of human immunodeficiency virus infection and drug use on birth characteristics. Obstet Cynecol 1996, 88:321-326.
9. Burns SM, Brettle RP, Gore SM, Peutherer JF, Robertson JR: The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum. J Infect 1996, 32:53-62.
10. De Vincenzi I: A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Eng J Med 1994, 331:341-346.
11. Lothian Health Board: AIDS Control Act Reports 1989/90-1995/96. Edinburgh: Lothian Health Board; 1996.
12. Bird AG, Gore SM, Joliffe DW, Burns SM: Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS 1992, 6:725-733.
13. Richardson AM, Davies AG: Serial prevalence study of HIV infection and HIV risk behaviour among injecting drug users in Edinburgh 1992-1994. ANSWER, November 1995, AM-17:WR95/47.
14. Brettle RP: HIV and harm reduction for injecting drug users. AIDS 1991, 5:125-136.
15. Bath GE, Dominy N, Burns SM, Peters A, Davies AC, Richardson AM: Injecting drug users in Edinburgh. Fewer drug users share needles [letter]. BMJ 1993, 306:1414.
16. Hamouda O, Willers H, Monch E, et al.: HIV seroprevalence in childbearing women bases on unlinked anonymous testing of newborns, 1993-1995. XI International Conference on AIDS. Vancouver, July 1996 [abstract Mo.C.458].
17. Ippolito G, Costa F, Stegagno M, Angeloni P, Angeloni U, Guzzanti E: Blind serosurvey of HIV antibodies in newborns in 92 Italian hospitals: a method for monitoring the infection rate in women at time of delivery. J Acquir Immune Defic Syndr 1991, 4:402-407.
18. Couturier E, Brossard Y, Larsen C, et al.: Prevalence de l'infection VIH chez les femmes enceintes de la region parisienne. Une enquete anonyme non correlee: PREVAGEST. Bull Epidemiol Hebdom 1991, 33:40-41.
19. Couturier E, Brossard Y, Larsen C, et al.: HIV infection at outcome of pregnancy in the Paris area, France. Lancet 1992, 340:707-709.
20. Couturier E, Brossard Y, Six C, et al.: Prevalence de l'infection VIH chez les femmes enceintes de la region parisienne. Une enquete anonyme non correlee: PREVAGEST: 1992-1993). Bull Epidemiol Hebdom 1993, 38:175-177.
21. Unlinked Anonymous Surveys Steering Group: Unlinked Anonymous HIV Prevalence Monitoring Programme England and Wales 1996. London: Department of Health; 1996: 37.
22. Ades AE, Parker S, Cubill D, et al.: Two methods for assessing the risk factor composition of the HIV-1 epidemic in heterosexual women: southeast England, 1988-1991. AIDS 1992, 6:1031-1036.
23. Nicoll A, McGarrigle C, Heptonstall J, et al.: Prevalence of HIV infection in pregnant women in London and elsewhere in England. BMJ 1994, 309:376-377.
24. MacDonagh SE, Masters J, Helps BA, Tookey PA, Ades AE, Gibb DM: Antenatal HIV testing in London: policy, update and detection. BMJ 1996, 313:532-533.
25. Connor EM, Sperling RD, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994, 331:1173-1180.